Weekly: Halozyme Therapeutics (HALO: $35.12) falls for a fourth consecutive week, a four-week fall of 12%; -$1.84 [5.0%] Vol Index 1.5 [1 is avg]

Media coverage

• Title	Weekly: Halozyme Therapeutics (HALO: $35.12) falls for a fourth consecutive week, a four-week fall of 12%; -$1.84 [5.0%] Vol Index 1.5 [1 is avg]
  Media name/outlet	Global Round Up - Bullish & Bearish Signals
  Country/Territory	United States
  Date	01/6/24
  Persons	Mary Daly